Anavex Life Sciences Corp. (AVXL)
4.415
+0.08
(+1.73%)
USD |
NASDAQ |
Dec 09, 16:00
4.415
0.00 (0.00%)
After-Hours: 18:26
Anavex Life Sciences EPS Diluted (Quarterly): -0.1144 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| ADMA Biologics, Inc. | 0.1489 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.825M |
| Total Expenses (Quarterly) | 9.825M |
| Enterprise Value | 285.19M |
| Earnings Yield | -12.32% |
| Normalized Earnings Yield | -12.32 |